ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Sodium hydride → [4-(4-[1,2,3]triazol-1-yl-butyl)phenyl]-{2-[(E)-2-(-4-trifluoromethanesulfinyl-phenyl)-vinyl]-oxazol-4-ylmethyl}-carbamic acid tert-butyl ester

HRID 1271439
印刷

反応式

HRID 1271439 の反応式
[C:1]([O:5][C:6](=[O:23])[NH:7][C:8]1[CH:13]=[CH:12][C:11]([CH2:14][CH2:15][CH2:16][CH2:17][N:18]2[CH:22]=[CH:21][N:20]=[N:19]2)=[CH:10][CH:9]=1)([CH3:4])([CH3:3])[CH3:2].[H-].[Na+].Cl[CH2:27][C:28]1[N:29]=[C:30]([CH:33]=[CH:34][C:35]2[CH:40]=[CH:39][C:38]([S:41]([C:43]([F:46])([F:45])[F:44])=[O:42])=[CH:37][CH:36]=2)[O:31][CH:32]=1.[Cl-].[NH4+]>CN(C)C=O>[C:1]([O:5][C:6](=[O:23])[N:7]([C:8]1[CH:13]=[CH:12][C:11]([CH2:14][CH2:15][CH2:16][CH2:17][N:18]2[CH:22]=[CH:21][N:20]=[N:19]2)=[CH:10][CH:9]=1)[CH2:27][C:28]1[N:29]=[C:30](/[CH:33]=[CH:34]/[C:35]2[CH:36]=[CH:37][C:38]([S:41]([C:43]([F:46])([F:44])[F:45])=[O:42])=[CH:39][CH:40]=2)[O:31][CH:32]=1)([CH3:4])([CH3:2])[CH3:3]
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 24758Sodium hydrideHCID 25517Ammonium ChlorideHCID 69220256[4-(4-[1,2,3]Triazol-1-yl-butyl)phenyl]-carbamic acid tert-butyl esterHCID 692923894-Chloromethyl-2-[2-(4-trifluoromethylsulfinyl-phenyl)-vinyl]-oxazole

生成物 1

HCID 69487104[4-(4-[1,2,3]triazol-1-yl-butyl)phenyl]-{2-[(E)-2-(-4-trifluoromethanesulfinyl-phenyl)-vinyl]-oxazol-4-ylmethyl}-carbamic acid tert-butyl ester
収率 29%

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒

実験手順

To an ice-cold solution of [4-(4-[1,2,3]triazol-1-yl-butyl)phenyl]-carbamic acid tert-butyl ester (188 mg, 0.6 mmol) in N,N-dimethylformamide (5 ml) was added sodium hydride (16.5 mg, 0.65 mmol) and the mixture stirred for 30 min. After addition of 4-chloromethyl-2-[2-(4-trifluoromethanesulfinyl-phenyl)-vinyl]-oxazole (200 mg, 0.6 mmol), the mixture was stirred at room temperature over night, then mixed with 40 ml ammonium chloride solution, thoroughly extracted with ethyl acetate and the extract dried and evaporated. Flash column chromatography (ethyl acetate/heptane 2:1) yielded 105 mg (29%) [4-(4-[1,2,3]triazol-1-yl-butyl)phenyl]-{2-[(E)-2-(−4-trifluoromethanesulfinyl-phenyl)-vinyl]-oxazol-4-ylmethyl}-carbamic acid tert-butyl ester as oily residue.

後処理

  1. stirringthe mixture was stirred at room temperature over night
  2. extractionthoroughly extracted with ethyl acetate
  3. customthe extract dried
  4. customevaporated

出典と根拠

ORDレコード
ord-9f3ffb4bb877405aa6dbf53b816f1601
出典データセット
uspto-grants-2007_04
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07205326B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート